INOVIQ: Confirms positive EXO-NET results in ovarian cancer study
INOVIQ Confirms positive EXO-NET results in ovarian cancer studyINOVIQ (IIQ) confirms positive results during its testing for ovarian cancer
The company wrapped up...
INOVIQ: Granted SubB2M US patent for diagnostic applications
INOVIQ Granted SubB2M US patent for diagnostic applicationsINOVIQ (IIQ) receives a US patent that covers its SubB2M technology and provides intellectual property protection...
INOVIQ: Receives Australian patent for SubB2M technology
INOVIQ Receives Australian patent for SubB2M technologyINOVIQ (IIQ) receives an Australian patent for its SubB2M technology, which the company now holds exclusive worldwide...

